. Invariant NKT (iNKT) cells, also known as type I NKT cells, are the most prevalent NKT cells in mice 7 and are the focus of this article. iNKT cells express a semi-invariant T cell receptor (TCR) that is composed of a single invariant TCR α-chain, which, in combination with certain TCR β-chains, recognizes the non-polymorphic MHC class I molecule CD1d.
From the onset of their discovery, iNKT cells have been shown to have some reactivity towards 'self ' . Some mouse iNKT cell hybridomas 8, 9 , a fraction of freshly isolated mouse iNKT thymocytes 9 and some human iNKT cell clones 10 have been shown to have TCR-dependent autoreactivity, which could be blocked by CD1d-specific antibodies. In all cases, reactivity was achieved in the absence of exogenous antigen in the cultures, but it was unclear whether the iNKT cell TCR recognized the CD1d molecule itself or whether CD1d might present some self glycolipid antigens to activate iNKT cell autoreactivity. The findings that CD1d molecules are absolutely required for the thymic development of iNKT cells [11] [12] [13] and that some iNKT cells respond to CD1d-expressing antigenpresenting cells (APCs), including thymocytes 9, 14 , bone marrow-derived dendritic cells (DCs) and various CD1d-transfected cell lines [15] [16] [17] [18] , suggested that the self antigen, or self antigens, presented by CD1d molecules for the positive selection of iNKT cells and the triggering of iNKT cell autoreactivity might in fact be the same. This notion is surprising when one considers that the self peptides that induce the positive selection of thymocytes are probably different from the foreign peptides that induce full cellular activation of mature conventional T cells 19 . Such a concept led to the hypothesis that iNKT cells are 'innate' lymphocytes that are autoreactive by 'design' 20 and are selected through the recognition of agonist self antigen (or self antigens) in the thymus. Consistent with this hypothesis, several markers that are usually associated with antigen-experienced T cells are expressed by iNKT cells during steady-state conditions [21] [22] [23] , and iNKT cells in the periphery constitutively express effector cytokine mRNA (encoding interleukin-4 (IL-4) and interferon-γ (IFNγ)) 24, 25 , suggesting that these cells might be continuously stimulated by self antigens. In addition to the role that this autoreactivity might have in surveillance against tumours 26, 27 , recent findings have revealed that iNKT cell activation can occur through the recognition of CD1d-restricted self antigens when combined with inflammatory cytokines released by APCs 28 . This observation introduces the possibility that iNKT cell activation could occur in response to virtually every infectious agent.
Understanding the nature of the self antigen (or self antigens) that is presented by CD1d and is crucial to the development and function of iNKT cells is therefore fundamental to defining the biological relevance of this cell population. Several self lipids and glycolipids have now been isolated and shown to be presented by CD1d; however, it is not clear which lipid (or lipids) is important for triggering iNKT cell autoreactivity and which lipid (or lipids) is responsible for the positive selection of iNKT cells in the thymus. Here, I review our current understanding of iNKT cell autoreactivity, discuss how it might be triggered and argue that several self lipids are probably involved in the process.
iNKT cell self antigens All of the currently identified microbial antigens that activate iNKT cells [29] [30] [31] [32] [33] share a common structure when bound with CD1d: a lipid tail buried in CD1d that is linked by an α-link to a sugar head that protrudes out of CD1d to be recognized by the iNKT cell TCR 34, 35 . However, any endogenous ligand for iNKT cells is likely to differ substantially from this structure, given that mammals cannot synthesize α-linked glycolipids.
CD1d molecules can capture self lipids in the endoplasmic reticulum-secretory pathway of APCs or in the endosomal or lysosomal compartment during recycling 36 . Many different self lipids, including phosphatidylethanolamine, phosphatidylinositol, phosphatidylcholine, phosphatidylglycerol, glycosylphosphatidylinositol, cardiolipin, sphingomyelin, lysophospholipids, plasmalogens, gangliosides and other glycosphingolipids have been shown to bind CD1d molecules [37] [38] [39] [40] . To date, one mouse iNKT cell hybridoma 41, 42 and one human iNKT cell clone 43 have been shown to respond to CD1d molecules loaded with phosphatidylethanolamine 16, 18, 45, 46 ; however, such requirements do not seem to apply to some human iNKT cell clones 47, 48 .
In agreement with the hypothesis that the self antigen (or self antigens) recognized by iNKT cells in peripheral tissues might be the same as that presented in the thymus during iNKT cell development, this endosomal loading of self antigens is also needed for the positive selection of mouse iNKT cells, as shown by mice expressing a tail-mutated version of CD1d that prevents its recycling in the endosomal compartment 45 . The glycosphingolipid β-glucosylceramide (β-GluCer), but not β-galactosylceramide (β-GalCer), has been proposed as a precursor of natural self antigen (or self antigens) presented by CD1d molecules to mouse iNKT cells 15, 49, 50 . Furthermore, mice lacking the lysosomal enzyme β-hexosaminidase subunit B (HeXB) were shown to have a severe decrease in the numbers of mature iNKT cells 38 . Therefore, glycosphingolipids with terminal N-acetylgalactosamine sugars, which are cleaved by β-hexosaminidases, were thought to be potential precursors for an iNKT cell ligand. However, only the β-linked glycosphingolipid isoglobotrihexosylceramide (iGb3) proved to be an agonist for mouse and human iNKT cells when presented by CD1d molecules in a cell-free assay 38 , and thymocytes from Hexb -/-mice failed to stimulate an iNKT cell hybridoma 38 , suggesting that iGb3 alone might be responsible for the thymic selection and the self reactivity of iNKT cells 51 . Recently, the role of iGb3 as the sole self antigen involved in iNKT cell autoreactivity and thymic selection has been challenged. iNKT cell deficiencies were found in several knockout mouse models that have an accumulation of glycosphingolipids in the endosomal or lysosomal compartment, irrespective of the specific glycosphingolipid targeted 52 . These results suggest that the deficiency in iNKT cells observed in Hexb -/-mice might be due to the nonspecific accumulation of glycosphingolipids, which may alter proper antigen loading of CD1d molecules in the endosomal compartment, rather than the absence of a particular self ligand. In addition, direct biochemical analysis of glycolipids isolated from mouse or human thymi and peripheral DCs failed to detect iGb3 (Refs 53,54), and mice deficient for iGb3 synthase (also known as A3GALT2) showed no obvious iNKT cell defect 53 . Finally, it was reported that humans lack a functional iGb3 synthase, and iGb3 is therefore absent in human APCs 55 . Together, these results suggested that iGb3 might not be essential for iNKT cell development and self recognition.
However, it is possible that minute quantities of iGb3 in the endosomal or lysosomal compartment could have been missed in the above analyses. Moreover, in the absence of functional iGb3 synthase, another biochemical pathway (or pathways) could potentially lead to the production of iGb3 (Ref. 56) . In fact, low levels of iGb3 in the mouse thymus, DCs 49 and a melanoma cell line 57 and of iGb4 in the human thymus 58 have been detected. But, if iGb3 is indeed the ligand responsible for the selection and autoreactivity of iNKT cells, how many iGb3-CD1d complexes on the cell surface of thymocytes or APCs are necessary and sufficient to induce positive selection and/or a response by iNKT cells? Recent studies showed that ~10 peptide-MHC complexes were needed for a sustained calcium response in CD4 + T cells 59 , and only three peptide-MHC complexes were needed for the induction of cytotoxicity by CD8 + T cells 60 . Considering these observations, perhaps minuscule quantities of iGb3 are relevant to iNKT cell autoreactivity and thymic selection. Alternatively, it is also possible that several self antigens, including iGb3, could trigger the autoreactivity of certain iNKT cell hybridomas and positively select iNKT cells in vivo.
Although the role of iGb3 as the only, or at least the dominant, selecting ligand is uncertain, it remains the most potent agonistic self antigen described to date. other β-linked glycosphingolipids, such as β-GalCer, have been shown to stimulate iNKT cells 61, 62 ; however, these results could be in part due to the potential contamination by α-linked glycosphingolipids that can occur during the synthesis of these compounds. Further experiments will clarify whether β-GalCer and other β-linked glycosphingolipids are bona fide iNKT cell antigens.
In addition to phospholipids and glycosphingolipids, glycodiacylglycerols could also include potential self antigens for iNKT cells. A glycodiacylglycerol purified from the Gram-negative bacteria Borrelia burgdorferi binds to CD1d molecules and can be recognized by iNKT cells 31 indicating that iNKT cell ligands are not limited to glycosphingolipids. Because glycodiacylglycerols, including monohexose α-linked diacylglycerol, have been identified in animal tissues 63, 64 , it is possible that self glyco diacylglycerols might also be self antigens for iNKT cells. Together, these data show that several, structurally unrelated, self lipids can potentially stimulate iNKT cells. It is not clear, however, whether human and mouse iNKT cells actually recognize different self antigens. we also do not know whether subpopulations of iNKT cells have distinct antigen specificities or whether the whole iNKT cell repertoire has the same antigenic specificity overall but only iNKT cells that express the highest affinity TCRs respond to the lowest affinity antigens. Finally, the circumstances leading to the presentation of each of these various self antigens and how they might be involved in triggering an iNKT cell response remain completely unknown.
Triggering an iNKT cell response to 'self' Although examples of iNKT cell autoreactivity clearly exist, most iNKT cells respond minimally to CD1d-expressing APCs. However, when APCs are exposed to microbial or viral pathogens, they can stimulate iNKT cells in a CD1d-dependent manner that does not require microbial or viral antigens. Therefore, APCs can sense pathogens and increase the autoreactivity of iNKT cells. Such a phenomenon might be mediated through the recognition of specific self antigen that is otherwise not presented in the steady state by CD1d molecules and/or that various foreign antigenindependent mechanisms that increase the sensitivity of the responding iNKT cells to self ligands might be at play.
weak responses to self-antigen-CD1d complexes by human CD1d-restricted T cell clones can be amplified by IL-12 produced by DCs in response to microbial products 30, 50, 65 (fIG. 1) . In addition, activation of nucleic acid sensors expressed by DCs, such as Toll-like receptor 9 (TLR9), can also indirectly trigger the production of IFNγ by iNKT cells 66 . However, whereas in some studies the activation of iNKT cells by TLR9-activated DCs depended on the secretion of IFNβ (or IL-12) and the recognition of self antigen (or self antigens) presented by CD1d 50, 66 , in other studies iNKT cell activation relied on the production of IL-12 but the need for CD1d expression was relatively minor [67] [68] [69] ; the reasons for these differences are unresolved.
The levels of CD1d expression by APCs following stimulation with microbial products might also modulate the activation threshold of iNKT cell autoreactivity. The expression of CD1d molecules have been shown to be upregulated on the surface of macrophages and peritoneal DCs in the presence of pro-inflammatory cytokines, microbial ligands 70, 71 , retinoic acid 72 and following infection by Salmonella enterica 73 or Listeria monocytogenes 71 . However, other studies did not observe increased CD1d expression levels on APCs following exposure to microbial products 50 . DC maturation results in increased expression of several adhesion and costimulatory molecules that could also contribute to enhanced iNKT cell autoreactivity (fIG. 1) . Interestingly, requirements for co-stimulation signals seem to differ between iNKT cells purified from different tissues 74 . This could potentially have important implications for the interpretation of experiments that measure iNKT cell autoreactivity. The tissue from which iNKT cells are isolated, how they are isolated and the type of APCs used to stimulate them in vitro 46 and replace otherwise weakly stimulatory self antigens that are usually presented by cD1d during steady state. These various possibilities to induce an iNKT cell response against 'self' are not mutually exclusive. β 2 m, β 2 -microglobulin.
probably influence the observed results. The differences of reactivity between iNKT cell hybridomas generated from different tissues were originally attributed to the expression of different self-antigen-CD1d complexes by different APCs 17, 18 . Although differences in glycosphingolipid profiling between different APCs (mature DCs versus B cells) exist, no consistent differences in the glycosphingolipid profiles between healthy human donors have been observed 75 ; however, preferential activation of iNKT cells by allogeneic APCs compared to syngenic APCs has been observed 75 . These results argue that APCs from different donors probably express the same self antigens loaded onto CD1d but can nevertheless differentially trigger autoreactive iNKT cell responses. This has been attributed to the differential expression of killer immunoglobulin receptors (KIRs) by different human iNKT cell lines and clones, the engagement of which by MHC class I molecules was suggested to prevent iNKT cell autoreactivity under steady-state conditions 75 . The dampening of iNKT cell autoreactivity through negative signals mediated by inhibitory receptors was also observed in purified hepatic mouse iNKT cells and could be reversed through the upregulation of co-stimulatory B7 molecules (also known as CD80 and CD86) on APCs 76 . Together these results suggest that, like NK cells, iNKT cell activation, although dependent on TCR-CD1d interaction, might also be regulated by a balance between stimulatory and inhibitory signals.
when taken together, the above results suggest that iNKT cells are inherently reactive to self antigens that are continually presented by CD1d molecules in the steady state, but, for most iNKT cells, their activation also requires a non antigenspecific signal that occurs during APC maturation after exposure to microorganisms. This does not preclude that a specific endogenous iNKT cell agonist antigen (or antigens) might also be generated following APC stimulation and might replace otherwise weakly stimulatory antigens loaded onto CD1d in immature APCs (fIG. 1) . engagement of TLR4, TLR7 and TLR9 has been shown to alter the level of mRNAs encoding several enzymes involved in the biosynthetic pathway of glycosphingolipids, including the enhanced expression of ceramide glucosyltransferase and enzymes implicated in the production of several glycosphingolipids 50, 66, 77 . Furthermore, APCs exposed to lipid extracts from TLR9-stimulated DCs, but not from naive DCs, can stimulate liver mononuclear cells (enriched for iNKT cells) when combined with pro-inflammatory cytokines 50, 66 . Interestingly, in these conditions, only charged (but not neutral) glycosphingolipids were shown to stimulate mononuclear cells. Mildly basic treatment of the lipid fractions, which destroys diacylglycerols and all lipids (such as phospholipids) except those based on β-GluCer, β-GalCer and ether lipids, did not reduce mononuclear cell activation. By contrast, digestion of the charged fractions with ceramide glycanase, which releases oligosaccharides from the GluCer-based glycosphingolipids, completely abrogated iNKT cell stimulation 66 . Together, the results suggested that charged glycosphingolipids might be synthesized in DCs following TLR stimulation and might be loaded onto CD1d to trigger iNKT cell autoreactivity when presented in conjunction with proinflammatory cytokines. However, similar experiments carried out by another group using glycosphingolipid fractions purified from TLR-stimulated DCs and human iNKT cell lines were inconclusive in regard to the nature of the glycosphingolipids that could elicit iNKT cell autoreactivity 50 . Nevertheless, following treatment with TLR ligands, APCs expressed higher levels of CD1d-bound ligands with higher TCR affinity than untreated APCs with identical CD1d expression levels 50 , suggesting that following TLR signalling, low affinity antigens loaded onto CD1d molecules might be replaced by higher affinity antigens.
These data show that TCR activation of iNKT cells by APCs can be achieved in several different ways. In some cases, the synthesis of new (unknown) self antigens with high affinity for the TCR might be involved, whereas in other cases the recognition of self antigens already presented by CD1d in the steady state is likely.
Antigen recognition by the iNKT cell TCR How do iNKT cell TCRs recognize both microbial α-linked glycolipids and structurally diverse (and still unknown) self antigens? Are the TCRs that are composed of different variable (V)β chains specific for different self antigens? what is the role of Vβ complementarity-determining region 3 (CDR3) diversity? Answering these fundamental questions will be key to our understanding of the diversity and nature of the CD1d-restricted self antigens that are crucial for the development and function of iNKT cells and will help in the design of iNKT cell ligands that will allow us to fine tune iNKT cell function.
Recent crystallographical and mutational analyses have begun to reveal how the iNKT cell TCR recognizes glycolipid-CD1d complexes. The crystal structures of one human and two mouse iNKT cell TCRs in complex with CD1d loaded with the prototypical antigen α-GalCer revealed a unique docking conformation that differed from most TCRpeptide-MHC interactions 78, 79 : the TCR of conventional T cells engages the MHC in an approximate diagonal orientation, whereas the TCR of iNKT cells docks at the very end of, and parallel to, the α-GalCer-CD1d complex (fIG. 2a) . The recognition of α-GalCerCD1d is mediated by germline-encoded residues located in the CDR1α, CDR3α and CDR2β loops of the TCR (fIG. 2b) . Although this unusual docking of the iNKT cell TCR has so far only been observed with α-GalCer-CD1d complexes 78, 79 , mutational analysis revealed that these TCR 'hot spots' are also required for the recognition of structurally different glycolipid antigens such as α-GalCer and iGb3 (Refs 80, 81) . Interestingly, CDR3β, the only hypervariable region of the iNKT cell TCR, does not make any direct contact with the antigen and instead is found positioned over the α2-helix of CD1d (fIG. 2c) . Although it remains unclear how this might happen structurally, the CDR3β loop can nevertheless similarly modulate the affinity of the iNKT cell TCR for various antigen-CD1d complexes 80, 82 . Because recognition of diverse glycolipid antigens requires the same germline-encoded residues, these observations suggest that the iNKT cell TCR might function as a patternrecognition receptor and be less ligand discriminating than conventional TCRs 80 . In this way, and in contrast to conventional T cells, different iNKT cell clones might have overlapping antigen specificity despite diversity in the TCRβ chain.
what, then, are the consequences of this overlapping specificity for iNKT cell autoreactivity? If we assume that the iNKT cell TCR recognizes different antigens in a similar manner and that the main difference between ligands is due to the affinity of recognition, then it is possible that various self antigens can be recognized by iNKT cells as long as they provide sufficient energy to the interaction or do not 'get in the way' . If this is indeed the case, then genetic approaches aimed at disrupting specific glycosidases to identify the self antigen (or self antigens) involved in positive selection and autoreactivity of iNKT cells might prove extremely difficult, if not impossible, owing to the potential redundancy in antigens and the disruption of antigen loading in the lysosomal compartment. Nature Reviews | Immunology A corollary to the previous hypothesis would be that by modifying the iNKT cell TCR so that it can interact optimally with CD1d, it might be possible to increase the affinity of the interaction between the TCR and the ligand-CD1d complexes so that it becomes ligand 'independent' . If true, this would suggest that unmanipulated iNKT cell TCRs have a suboptimal affinity for CD1d molecules that are presenting self antigens. In the context of enhanced co-stimulation or cytokine production by APCs, this affinity might be sufficient to induce the activation of iNKT cells. By manipulating the sequences of Vβ CDR2 and CDR3 loops, we recently isolated iNKT cell TCRs that interact with 'unloaded' CD1d tetramers 82 . Hybridomas engineered to express these TCRs are highly autoreactive and respond strongly to CD1d-expressing APCs (T. Mallevaey, J. Scott-Browne and L.G., unpublished observations). These results support the hypothesis that iNKT cell autoreactivity might be due to the recognition of a broad range of self lipids presented by CD1d with varying agonist activities.
Conclusions
The discovery that some iNKT cells in mice and humans can respond to CD1d-expressing APCs in the absence of exogenous antigen has shaped our understanding of iNKT cell biology. It has become increasingly apparent that the observed autoreactivity of certain iNKT cell hybridomas or clones is a complex phenomenon regulated by many components. The affinity and the expression level of TCRs by some of these clones, their requirement for co-stimulation, the levels of CD1d expression and the need for CD1d aggregation in the plasma membrane of APCs 83 , and the presence of pro-inflammatory cytokines and high-affinity self antigen (or self antigens) presented by CD1d are all likely to be important parameters that can modulate iNKT cell autoreactivity. our recent findings regarding the iNKT cell TCR specificity argue that several self antigens can be similarly recognized by different iNKT cell TCRs with different affinities. This innocuous hypothesis has far-reaching implications for iNKT cell biology, as it implies that several self antigens may be responsible for the positive selection of iNKT cells and the autoreactivity of these cells in peripheral tissues. The next challenge will be to determine which of these self antigens, when loaded onto CD1d molecules, can bind the iNKT cell TCR and subsequently what role, if any, these self-antigen-CD1d complexes might have in the thymic selection of iNKT cells and their activation in the periphery. of the mouse iNKT cell Tcr interaction with α-Galcer-cD1d complex. cDr3α mediates several contacts between mouse cD1d α-helices (grey) and α-Galcer. residues in the cDr2β loop contact the α1-helix of mouse cD1d. cDr1α interacts solely with the α-Galcer galactose head group. Other cDr loops are not depicted for purposes of clarity. c | superposition of human vα24-vβ11 iNKT cell Tcr (yellow) on human cD1d, mouse vα14-vβ8.2 (green) on mouse cD1d and mouse vα14-vβ7 (pink) on mouse cD1d. cD1d molecules are shown in grey. Only the cDr1α, cDr3α, cDr2β and cDr3β loops of each Tcr are depicted for clarity. Note the location of the cDr3β loops over the α2-helix of cD1d. The cDr3β of the vα14-vβ8.2 Tcr is not depicted as it was mobile and hence could not be resolved on the crystal structure 79 . The coordinates of the mouse vα14Jα18-vβ8.2 iNKT cell Tcr-α-GalcercD1d, mouse vα14Jα18-vβ7 iNKT cell Tcr-α-Galcer-cD1d and the human vα24Jα18-vβ11 iNKT cell Tcr-α-Galcer-cD1d complexes are available in the research collaboratory for structural Bioinformatics Protein Data Bank under accession numbers 3He6, 3He7 and 2PO6, respectively. α-Galcer, α-galactosylceramide; β 2 m, β 2 -microglobulin; cDr3α, complementarity-determining region 3α; iNKT, invariant natural killer T cell; Tcr, T cell receptor; v, variable.
